Who Owns Gene Editing? Patents in the Time of CRISPR

Biochemist, Vol. 38, p. 26 (2016)

NYLS Legal Studies Research Paper No. 2915853

4 Pages Posted: 16 Feb 2017

See all articles by Jacob S. Sherkow

Jacob S. Sherkow

University of Illinois College of Law; Carle Illinois College of Medicine; University of Illinois at Urbana-Champaign - European Union Center; University of Illinois at Urbana-Champaign - Carl R. Woese Institute for Genomic Biology

Date Written: April 5, 2016

Abstract

New gene-editing technologies, like CRISPR, promise revolutionary advances in biology and medicine. However, several patent disputes in the USA and UK may have complicated who can use CRISPR. What does this mean for the future of gene editing?

Keywords: intellectual property, patent, biotech, biotechnology, crispr, genetics

JEL Classification: K00, K23, K41, O3, O34, D23, K11

Suggested Citation

Sherkow, Jacob S., Who Owns Gene Editing? Patents in the Time of CRISPR (April 5, 2016). Biochemist, Vol. 38, p. 26 (2016), NYLS Legal Studies Research Paper No. 2915853, Available at SSRN: https://ssrn.com/abstract=2915853

Jacob S. Sherkow (Contact Author)

University of Illinois College of Law ( email )

504 E. Pennsylvania Avenue
Champaign, IL 61820
United States

Carle Illinois College of Medicine ( email )

506 S Mathews Ave
Urbana, IL 61801
United States

University of Illinois at Urbana-Champaign - European Union Center ( email )

Coble Hall
801 S Wright St
Champaign, IL 61820

University of Illinois at Urbana-Champaign - Carl R. Woese Institute for Genomic Biology ( email )

Urbana, IL
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
535
Abstract Views
1,759
Rank
95,292
PlumX Metrics